Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nurix Therapeutics Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Interest Income Expense
$11.1m
CAGR 3-Years
109%
CAGR 5-Years
68%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
10%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$1.1B
CAGR 3-Years
29%
CAGR 5-Years
-12%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$3.9B
CAGR 3-Years
-61%
CAGR 5-Years
-41%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$621.3m
CAGR 3-Years
315%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$697.5m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nurix Therapeutics Inc's Interest Income Expense?
Interest Income Expense
11.1m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Interest Income Expense amounts to 11.1m USD.

What is Nurix Therapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
68%

Over the last year, the Interest Income Expense growth was 217%. The average annual Interest Income Expense growth rates for Nurix Therapeutics Inc have been 109% over the past three years , 68% over the past five years .

Back to Top